About this Journal Submit a Manuscript Table of Contents
Clinical and Developmental Immunology
Volume 2013 (2013), Article ID 474028, 9 pages
http://dx.doi.org/10.1155/2013/474028
Clinical Study

Higher Levels of Autoantibodies Targeting Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis Than in Patients with Psoriasis Vulgaris

1Department of Dermatology and Allergology, University of Szeged, 6 Korányi Fasor, Szeged 6720, Hungary
2Department of Rheumatology, University of Szeged, 57 Kálvária Sugárút, Szeged 6725, Hungary
3Erzsébet Hospital, Hódmezővásárhely, Rheumatology and Rehabilitation Center of Kakasszék, 143 IV. Kerület, Székkutas 6821, Hungary
4Dermatological Research Group of the Hungarian Academy of Sciences, University of Szeged, 6 Korányi Fasor, Szeged 6720, Hungary

Received 12 October 2012; Revised 23 December 2012; Accepted 2 January 2013

Academic Editor: Xavier Bossuyt

Copyright © 2013 Szandra Dalmády et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Szandra Dalmády, Mária Kiss, László Képíró, et al., “Higher Levels of Autoantibodies Targeting Mutated Citrullinated Vimentin in Patients with Psoriatic Arthritis Than in Patients with Psoriasis Vulgaris,” Clinical and Developmental Immunology, vol. 2013, Article ID 474028, 9 pages, 2013. doi:10.1155/2013/474028